A team led by VA and Stanford University School of Medicine researchers has identified three genetic mutations that govern cholesterol levels. The finding could lead to the development of new drugs to treat cardiovascular disease and diabetes.https://www.research.va.gov/currents/1018-MVP-study-on-cholesterol-genetics-could-lead-to-new-treatments-for-heart-disease-diabetes.cfm